Related content

The Future of NMR Metabolomics in Cancer Therapy: Towards Personalizing Treatment and Developing Targeted Drugs?

By Palmnas Marie S.A.   Vogel Hans J  

Metabolites, Vol. 3, Iss. 2, 2013-05 ,pp. : 373-396

MDPI

Access to resources Recommend Favorite

Chronic Intracerebroventricular Administration of Relaxin-3 Increases Body Weight in Rats

By HIDA TAKAYUKI   TAKAHASHI EIKI   SHIKATA KODO   HIROHASHI TOMOKO   SAWAI TORU   SEIKI TAKASHI   TANAKA HIROKAZU   KAWAI TAKATOSHI   ITO OSAMU   ARAI TORU   YOKOI AKIRA   HIRAKAWA TETSUYA   OGURA HIROO   NAGASU TAKESHI   MIYAMOTO NORIMASA   KUROMITSU JUNRO  

Journal of Receptors and Signal Transduction, Vol. 26, Iss. 3, 2006-06 ,pp. : 147-158

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effects of relaxin on cardiac fibroblast‐to‐myofibroblast transition: an electrophysiological study

By  

EXPERIMENTAL PHYSIOLOGY (ELECTRONIC), Vol. 100, Iss. 6, 2015-06 ,pp. : 652-666

John Wiley & Sons Inc

Access to resources Recommend Favorite

Involvement of central relaxin‐3 signalling in sodium (salt) appetite

By  

EXPERIMENTAL PHYSIOLOGY (ELECTRONIC), Vol. 100, Iss. 9, 2015-09 ,pp. : 1064-1072

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like behaviors in rats based on a microarray and peptidome analysis

By Nakazawa Chihiro Miyamoto   Shikata Kohdoh   Uesugi Mai   Katayama Hiroyuki   Aoshima Ken   Tahara Kazuhiro   Takahashi Eiki   Hida Takayuki   Shibata Hisashi   Ogura Hiroo   Seiki Takashi   Oda Yoshiya   Kuromitsu Junro   Miyamoto Norimasa  

Journal of Receptors and Signal Transduction, Vol. 33, Iss. 4, 2013-08 ,pp. : 224-233

Informa Healthcare

Access to resources Recommend Favorite